Ania Tassinari

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Cardiac Surgery

Top Venues

Nature medicine

Science (New York, N.Y.)

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, Lei Shi, Yi Xiao, Sofiene Dhiab, Qin Xu, Chloe J Slater, Omar I Avila, Joshua Merritt, Hiroyuki Kato, Prabhat Kattel, Jonathan H Sussman, Ilaria Gritti, Jason Eccleston, Yi Sun, Hyo Min Cho, Kira E Olander, Takeshi Katsuda, Diana D Shi, Milan R Savani, Bailey C Smith, James M Cleary, Raul Mostoslavsky, Vindhya Vijay, Yosuke Kitagawa, Hiroaki Wakimoto, Russell William Jenkins, Kathleen B Yates, Jihye Paik, Ania Tassinari, Hatice Duygu Saatcioglu, Adriana E Tron, Wilhelm Haas, Daniel P Cahill, Samuel K McBrayer, Robert T Manguso, Nabeel El-Bardeesy
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity. Science (New York, N.Y.) 385 (6705) (2024)
Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, Lei Shi, Yi Xiao, Sofiene Dhiab, Qin Xu, Chloe J Slater, Omar I Avila, Joshua Merritt, Hiroyuki Kato, Prabhat Kattel, Jonathan H Sussman, Ilaria Gritti, Jason Eccleston, Yi Sun, Hyo Min Cho, Kira E Olander, Takeshi Katsuda, Diana D Shi, Milan R Savani, Bailey C Smith, James M Cleary, Raul Mostoslavsky, Vindhya Vijay, Yosuke Kitagawa, Hiroaki Wakimoto, Russell William Jenkins, Kathleen B Yates, Jihye Paik, Ania Tassinari, Hatice Duygu Saatcioglu, Adriana E Tron, Wilhelm Haas, Daniel P Cahill, Samuel K McBrayer, Robert T Manguso, Nabeel El-Bardeesy
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity. Science (New York, N.Y.) 385 (6705) (2024)
Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, Lei Shi, Yi Xiao, Sofiene Dhiab, Qin Xu, Chloe J Slater, Omar I Avila, Joshua Merritt, Hiroyuki Kato, Prabhat Kattel, Jonathan H Sussman, Ilaria Gritti, Jason Eccleston, Yi Sun, Hyo Min Cho, Kira E Olander, Takeshi Katsuda, Diana D Shi, Milan R Savani, Bailey C Smith, James M Cleary, Raul Mostoslavsky, Vindhya Vijay, Yosuke Kitagawa, Hiroaki Wakimoto, Russell William Jenkins, Kathleen B Yates, Jihye Paik, Ania Tassinari, Hatice Duygu Saatcioglu, Adriana E Tron, Wilhelm Haas, Daniel P Cahill, Samuel K McBrayer, Robert T Manguso, Nabeel El-Bardeesy
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity. Science (New York, N.Y.) 385 (6705) (2024)
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, Jennie W Taylor, Elizabeth A Maher, Isabel Arrillaga-Romany, Katherine B Peters, Benjamin M Ellingson, Marc K Rosenblum, Saewon Chun, Kha Le, Ania Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S Pandya, Islam Hassan, Lori Steelman, Jennifer L Clarke, Timothy F Cloughesy
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nature medicine 29 (3) (2023)
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, Jennie W Taylor, Elizabeth A Maher, Isabel Arrillaga-Romany, Katherine B Peters, Benjamin M Ellingson, Marc K Rosenblum, Saewon Chun, Kha Le, Ania Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S Pandya, Islam Hassan, Lori Steelman, Jennifer L Clarke, Timothy F Cloughesy
Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nature medicine (2023)
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, Jennie W Taylor, Elizabeth A Maher, Isabel Arrillaga-Romany, Katherine B Peters, Benjamin M Ellingson, Marc K Rosenblum, Saewon Chun, Kha Le, Ania Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S Pandya, Islam Hassan, Lori Steelman, Jennifer L Clarke, Timothy F Cloughesy
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nature medicine 29 (3) (2023)
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, Jennie W Taylor, Elizabeth A Maher, Isabel Arrillaga-Romany, Katherine B Peters, Benjamin M Ellingson, Marc K Rosenblum, Saewon Chun, Kha Le, Ania Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S Pandya, Islam Hassan, Lori Steelman, Jennifer L Clarke, Timothy F Cloughesy
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nature medicine (2023)
Elia Aguado-Fraile, Ania Tassinari, Yuko Ishii, Carlie S Sigel, Maeve A Lowery, Lipika Goyal, Camelia Gliser, Liewen Jiang, Shuchi S Pandya, Bin Wu, Nabeel El-Bardeesy, Sung Choe, Vikram Deshpande
Molecular and morphological changes induced by ivosidenib correlate with efficacy in mutant-IDH1 cholangiocarcinoma. Future oncology (London, England) 17 (16) (2021)